Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

1.

Occupational exposure to polycyclic aromatic hydrocarbons influenced neither the frequency nor the spectrum of FGFR3 mutations in bladder urothelial carcinoma.

Bakkar AA, Allory Y, Iwatsubo Y, de Medina SG, Maille P, Khreich N, Riou A, Leroy K, Vordos D, Abbou CC, Andujar P, Billebaud T, Chammings S, Conso F, De La Taille A, Fontaine E, Gattegno B, Ravery V, Sibony M, Radvanyi F, Chopin DK, Pairon JC.

Mol Carcinog. 2010 Jan;49(1):25-31. doi: 10.1002/mc.20573.

PMID:
19722178
[PubMed - indexed for MEDLINE]
2.

Genetic susceptibility to distinct bladder cancer subphenotypes.

Guey LT, García-Closas M, Murta-Nascimento C, Lloreta J, Palencia L, Kogevinas M, Rothman N, Vellalta G, Calle ML, Marenne G, Tardón A, Carrato A, García-Closas R, Serra C, Silverman DT, Chanock S, Real FX, Malats N; EPICURO/Spanish Bladder Cancer Study investigators.

Eur Urol. 2010 Feb;57(2):283-92. doi: 10.1016/j.eururo.2009.08.001. Epub 2009 Aug 12.

PMID:
19692168
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Cancer statistics, 2009.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ.

CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.

PMID:
19474385
[PubMed - indexed for MEDLINE]
Free Article
4.

Estrogen modulates permeability and prostaglandin levels in the rabbit urinary bladder.

Hass MA, Nichol P, Lee L, Levin RM.

Prostaglandins Leukot Essent Fatty Acids. 2009 Feb-Mar;80(2-3):125-9. doi: 10.1016/j.plefa.2008.11.010. Epub 2009 Jan 31.

PMID:
19181506
[PubMed - indexed for MEDLINE]
5.

Bladder cancer develops 6 years earlier in current smokers: analysis of bladder cancer registry data collected by the cancer registration committee of the Japanese Urological Association.

Hinotsu S, Akaza H, Miki T, Fujimoto H, Shinohara N, Kikuchi E, Mizutani Y, Koga H, Okajima E, Okuyama A; Japanese Urological Association.

Int J Urol. 2009 Jan;16(1):64-9. doi: 10.1111/j.1442-2042.2008.02194.x. Epub 2008 Nov 27.

PMID:
19054170
[PubMed - indexed for MEDLINE]
6.

The management of superficial bladder cancer.

Dalbagni G.

Nat Clin Pract Urol. 2007 May;4(5):254-60. Review.

PMID:
17483810
[PubMed - indexed for MEDLINE]
7.

Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.

Wolff EM, Liang G, Jones PA.

Nat Clin Pract Urol. 2005 Oct;2(10):502-10. Review.

PMID:
16474624
[PubMed - indexed for MEDLINE]
8.

Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?

Knowles MA.

Carcinogenesis. 2006 Mar;27(3):361-73. Epub 2005 Dec 13. Review.

PMID:
16352616
[PubMed - indexed for MEDLINE]
Free Article
9.

Urothelial tumorigenesis: a tale of divergent pathways.

Wu XR.

Nat Rev Cancer. 2005 Sep;5(9):713-25. Review.

PMID:
16110317
[PubMed - indexed for MEDLINE]
10.

COX-2-derived prostacyclin confers atheroprotection on female mice.

Egan KM, Lawson JA, Fries S, Koller B, Rader DJ, Smyth EM, Fitzgerald GA.

Science. 2004 Dec 10;306(5703):1954-7. Epub 2004 Nov 18.

PMID:
15550624
[PubMed - indexed for MEDLINE]
Free Article
11.

Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer.

Pruthi RS, Derksen E, Gaston K, Wallen EM.

Urology. 2004 Oct;64(4):637-42. Review. No abstract available.

PMID:
15491687
[PubMed - indexed for MEDLINE]
12.

Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer.

Hazra A, Grossman HB, Zhu Y, Luo S, Spitz MR, Wu X.

Genes Chromosomes Cancer. 2004 Dec;41(4):330-8.

PMID:
15390186
[PubMed - indexed for MEDLINE]
13.

Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens.

Wallerand H, Bakkar AA, de Medina SG, Pairon JC, Yang YC, Vordos D, Bittard H, Fauconnet S, Kouyoumdjian JC, Jaurand MC, Zhang ZF, Radvanyi F, Thiery JP, Chopin DK.

Carcinogenesis. 2005 Jan;26(1):177-84. Epub 2004 Sep 3.

PMID:
15347601
[PubMed - indexed for MEDLINE]
Free Article
14.

Gender- and smoking-related bladder cancer risk.

Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Ross RK, Yu MC.

J Natl Cancer Inst. 2001 Apr 4;93(7):538-45.

PMID:
11287448
[PubMed - indexed for MEDLINE]
Free Article
15.
16.

Regulation of prostaglandin endoperoxide H synthase 1 and 2 by estradiol and progesterone in nonpregnant ovine myometrium and endometrium in vivo.

Wu WX, Ma XH, Zhang Q, Buchwalder L, Nathanielsz PW.

Endocrinology. 1997 Sep;138(9):4005-12.

PMID:
9275092
[PubMed - indexed for MEDLINE]
17.

Vitamin E inhibits apoptosis, DNA modification, and cancer incidence induced by iron-mediated peroxidation in Wistar rat kidney.

Zhang D, Okada S, Yu Y, Zheng P, Yamaguchi R, Kasai H.

Cancer Res. 1997 Jun 15;57(12):2410-4.

PMID:
9192818
[PubMed - indexed for MEDLINE]
Free Article
18.

Are the known bladder cancer risk-factors associated with more advanced bladder cancer?

Hayes RB, Friedell GH, Zahm SH, Cole P.

Cancer Causes Control. 1993 Mar;4(2):157-62.

PMID:
8481494
[PubMed - indexed for MEDLINE]
19.

Associations between bladder cancer risk factors and tumor stage and grade at diagnosis.

Sturgeon SR, Hartge P, Silverman DT, Kantor AF, Linehan WM, Lynch C, Hoover RN.

Epidemiology. 1994 Mar;5(2):218-25.

PMID:
8172997
[PubMed - indexed for MEDLINE]
20.

Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder.

Raitanen MP, Nieminen P, Tammela TL.

Br J Urol. 1995 Oct;76(4):470-4.

PMID:
7551884
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk